Navigation Links
Ivera Medical Announces Patent Award for Curos® Port Protectors
Date:6/13/2012

SAN DIEGO, June 13, 2012 /PRNewswire/ -- Ivera Medical Corporation announced today that the United States Patent & Trademark Office (USPTO) will issue a new continuation patent for its innovative Curos® disinfecting port protector technology on June 26, 2012.  U.S. Patent No. 8,206,514 will cover key aspects of disinfecting caps designed to be used with luer-activated IV valves to disinfect and clean the IV port.

IV therapy is the primary route for drug therapy in the acute care setting. However, traditional IV access management techniques, including "scrub the hub" protocols have failed to protect patients as evidenced by the approximately 87 percent of bloodstream infections associated with the presence of some type of intravascular device.

Ivera Medical's Curos Port Protector is a simple, innovative, disposable medical device that effectively disinfects luer-activated needleless valves, killing the organisms associated with patient bloodstream infection. With two dispenser options—the Curos Strip or individual Curos—nurses can conveniently comply with disinfection protocols by simply peeling the foil seal off the distinctive green cap and twisting Curos over the top of any luer-activated IV access port or needleless valve. Inside Curos a 70% IPA (isopropyl alcohol) saturated sponge-like foam automatically provides effective, consistent and reliable passive disinfection of the port. The use of Curos eliminates training and technique-related issues while providing an unequivocal indicator that an IV access site is clean.

"This patent further strengthens our patent protection within the disinfection cap arena," stated Bob Rogers, chief executive officer of Ivera Medical. "We continue to develop our intellectual property to ensure that Ivera is well-positioned to bring new and better disinfection solutions to market."

About Ivera Medical

Ivera Medical Corporation is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient infections. Curos®, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received FDA's 510(k) market clearance. For more information about Curos and Ivera Medical, visit the website at http://www.iveramed.com.

Contact:
Bob Rogers
Chief Executive Officer
Ivera Medical Corp.
Bob.rogers@iveramed.com
760-612-6090


'/>"/>
SOURCE Ivera Medical Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ivera Medical Corporation Denies Patent Infringement Allegations
2. Oriel STAT A MATRIX Welcomes New Global Practice Head for Medical Devices and Life Sciences
3. Global Market for Medical Imaging Equipment to Reach $25.3 Billion as Retiring Boomers and Emerging Markets Demand Better Healthcare
4. This Week: UBM Canon Presents an Online Event and Conference Dedicated to Emerging Trends in Medical Device Outsourcing/Contract Manufacturing
5. Aethlon Medical (AEMD) Note: Cancer Research Discovery - Melanoma Exosomes Fuel Organ Metastasis
6. NexGen Biomedical, Inc. Provides New Insights Into Jett Travoltas Seizure Related Death
7. Emerging Trends in Medical Device Outsourcing and Contract Manufacturing
8. Nonin Medicals Tissue Oximetry System Recognized at Premier Healthcare Alliance Innovation Celebration
9. Nonin Medical, Inc. Announces U.S. Market Release of EQUANOX™ Advance Model 8004CB Series Sensor for Neonatal, Pediatric Patients
10. Aircraft Medical Launches the McGRATH® MAC 2 Blade for Paediatric Patients
11. New Medical Device Study Offers Key Marketing Budget and Staffing Metrics to Promote Effective Use of Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... While it’s often important to take certain medications during the night, finding ... identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL BOX to ... the need to turn on a light when taking medication during the night, allowing ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
Breaking Medicine News(10 mins):